Interventions for the management of malignant pleural effusions: An updated network meta-analysis

Alexandra S L Dipper; Hayley E Jones; Rahul Bhatnagar; Nancy J  Preston; Nick A Maskell; Amelia  Clive

doi:10.1183/16000617.0025-2021

Interventions for the management of malignant pleural effusions: An updated network meta-analysis

Alexandra S L Dipper, Hayley E Jones, Rahul Bhatnagar, Nancy J Preston , Nick A Maskell^*, Amelia Clive

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

13 Citations (Scopus)

90 Downloads (Pure)

Abstract

[No Abstract]

Original language	English
Article number	210025
Number of pages	3
Journal	European Respiratory Review
Volume	30
Issue number	160
DOIs	https://doi.org/10.1183/16000617.0025-2021
Publication status	Published - 5 May 2021

Bibliographical note

Funding Information:
Conflict of interest: A. Dipper reports grants from National Institute for Health Research, during the conduct of the study. H.E. Jones reports grants from NICE Guidelines Technical Support Unit, University of Bristol, during the conduct of the study. R. Bhatnagar reports grants from National Institute for Health Research, during the conduct of the study; and was the trial coordinator for the TAPPS and IPC-Plus studies but did not perform the data extractions, or any assessments of risk of bias or GRADE, for these studies for the purposes of this article. N.J. Preston has nothing to disclose. N. Maskell reports grants from National Institute for Health Research, during the conduct of the study; and grants from Becton Dickenson, outside the submitted work. He was a member of the trial steering committee for TIME-1 and TIME-3 trials and co-author for one of the included studies in this article. He did not perform the data extractions, or any assessments of risk of bias or GRADE, for these studies for the purposes of this article. A. Clive reports grants from National Institute for Health Research, during the conduct of the study. She was involved in coordinating and recruiting to the TIME-3 trial and the TAPPS trial and assisted with the data analysis. She did not perform the data extraction, or any assessments of risk of bias or GRADE, for these studies for the purpose of this article.

Funding Information:
In 2019, the National Institute for Health and Care Excellence (NICE) in the UK commissioned the priority updating of this review to inform the guidance ?Lung cancer: diagnosis and management? (NG122) (NIHR Project Reference: NIHR 129794).

Research Groups and Themes

Academic Respiratory Unit

Access to Document

10.1183/16000617.0025-2021

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via European Respiratory Society at https://doi.org/10.1183/16000617.0025-2021 . Please refer to any applicable terms of use of the publisher.
Final published version, 257 KBLicence: CC BY

Handle.net

Persistent link

Embargoed Document

Full-text PDF (author accepted manuscript)
Accepted author manuscript, 198 KB

Optimising the management of malignant pleural effusion
Dipper, A. S. L. (Author), Maskell, N. (Supervisor) & Bhatnagar, R. (Supervisor), 18 Jun 2024
Student thesis: Doctoral Thesis › Doctor of Philosophy (PhD)

File

Cite this

@article{fe581f748f4149f292fb73f5a9bdbfa1,

title = "Interventions for the management of malignant pleural effusions: An updated network meta-analysis",

abstract = "[No Abstract]",

author = "Dipper, \{Alexandra S L\} and Jones, \{Hayley E\} and Rahul Bhatnagar and Preston, \{Nancy J\} and Maskell, \{Nick A\} and Amelia Clive",

note = "Funding Information: Conflict of interest: A. Dipper reports grants from National Institute for Health Research, during the conduct of the study. H.E. Jones reports grants from NICE Guidelines Technical Support Unit, University of Bristol, during the conduct of the study. R. Bhatnagar reports grants from National Institute for Health Research, during the conduct of the study; and was the trial coordinator for the TAPPS and IPC-Plus studies but did not perform the data extractions, or any assessments of risk of bias or GRADE, for these studies for the purposes of this article. N.J. Preston has nothing to disclose. N. Maskell reports grants from National Institute for Health Research, during the conduct of the study; and grants from Becton Dickenson, outside the submitted work. He was a member of the trial steering committee for TIME-1 and TIME-3 trials and co-author for one of the included studies in this article. He did not perform the data extractions, or any assessments of risk of bias or GRADE, for these studies for the purposes of this article. A. Clive reports grants from National Institute for Health Research, during the conduct of the study. She was involved in coordinating and recruiting to the TIME-3 trial and the TAPPS trial and assisted with the data analysis. She did not perform the data extraction, or any assessments of risk of bias or GRADE, for these studies for the purpose of this article. Funding Information: In 2019, the National Institute for Health and Care Excellence (NICE) in the UK commissioned the priority updating of this review to inform the guidance ?Lung cancer: diagnosis and management? (NG122) (NIHR Project Reference: NIHR 129794).",

year = "2021",

month = may,

day = "5",

doi = "10.1183/16000617.0025-2021",

language = "English",

volume = "30",

journal = "European Respiratory Review",

issn = "0905-9180",

publisher = "European Respiratory Society",

number = "160",

}

TY - JOUR

T1 - Interventions for the management of malignant pleural effusions

T2 - An updated network meta-analysis

AU - Dipper, Alexandra S L

AU - Jones, Hayley E

AU - Bhatnagar, Rahul

AU - Preston , Nancy J

AU - Maskell, Nick A

AU - Clive , Amelia

N1 - Funding Information: Conflict of interest: A. Dipper reports grants from National Institute for Health Research, during the conduct of the study. H.E. Jones reports grants from NICE Guidelines Technical Support Unit, University of Bristol, during the conduct of the study. R. Bhatnagar reports grants from National Institute for Health Research, during the conduct of the study; and was the trial coordinator for the TAPPS and IPC-Plus studies but did not perform the data extractions, or any assessments of risk of bias or GRADE, for these studies for the purposes of this article. N.J. Preston has nothing to disclose. N. Maskell reports grants from National Institute for Health Research, during the conduct of the study; and grants from Becton Dickenson, outside the submitted work. He was a member of the trial steering committee for TIME-1 and TIME-3 trials and co-author for one of the included studies in this article. He did not perform the data extractions, or any assessments of risk of bias or GRADE, for these studies for the purposes of this article. A. Clive reports grants from National Institute for Health Research, during the conduct of the study. She was involved in coordinating and recruiting to the TIME-3 trial and the TAPPS trial and assisted with the data analysis. She did not perform the data extraction, or any assessments of risk of bias or GRADE, for these studies for the purpose of this article. Funding Information: In 2019, the National Institute for Health and Care Excellence (NICE) in the UK commissioned the priority updating of this review to inform the guidance ?Lung cancer: diagnosis and management? (NG122) (NIHR Project Reference: NIHR 129794).

PY - 2021/5/5

Y1 - 2021/5/5

N2 - [No Abstract]

AB - [No Abstract]

U2 - 10.1183/16000617.0025-2021

DO - 10.1183/16000617.0025-2021

M3 - Article (Academic Journal)

C2 - 33952602

SN - 0905-9180

VL - 30

JO - European Respiratory Review

JF - European Respiratory Review

IS - 160

M1 - 210025

ER -

Interventions for the management of malignant pleural effusions: An updated network meta-analysis

Abstract

Bibliographical note

Research Groups and Themes

Access to Document

Handle.net

Embargoed Document

Fingerprint

Student theses

Optimising the management of malignant pleural effusion

Cite this